Guidehouse Adds Tech and Strategy Talent to Growing Life Sciences Practice
Mark Rodgers and Indraneel Mukherjee to help brands optimize product launch with robust strategies and advanced technology MCLEAN, Va., Aug....
Mark Rodgers and Indraneel Mukherjee to help brands optimize product launch with robust strategies and advanced technology MCLEAN, Va., Aug....
DARPA's EQUIP-A-Pharma program will leverage a customized chemical synthesis platform and Aprecia's 3D printing technology to demonstrate agile manufacturing applications...
First fully integrated spatial multiomic assay from 10x Genomics brings RNA and protein data together in situ – unlocking deeper...
In this free webinar, learn how streamlined workflows and intuitive interfaces help pathologists reduce time spent on slide review and...
New solution provides hospitals and health systems with the foresight and tools to plan for drug shortages before disruptions occur...
KENNESAW, GA / ACCESS Newswire / August 19, 2025 / The world of healthcare has changed drastically since the COVID-19...
ALEXANDRIA, VA / ACCESS Newswire / August 19, 2025 / The American Society of Consultant Pharmacists (ASCP) proudly announces the...
DENVER, COLORADO / ACCESS Newswire / August 19, 2025 / ForCast Orthopedics today announced the expansion of its Scientific Advisory...
Accelerated Round Completion Positions Company for New Drug Application (NDA) Submission and Commercial Launch Partnerships RALEIGH, NORTH CAROLINA / ACCESS...
MESA, ARIZONA / ACCESS Newswire / August 19, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today provided a corporate...
GRAND RAPIDS, MI / ACCESS Newswire / August 19, 2025 / SpendMend, a leading provider of solutions to optimize the...
As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral...
~Full Commercial Launch with Expanded Number of Instrument Sets and Field Support to Meet Growing Market Demand ~~ New SI...
Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4...
~ The Summit is the Premier Industry Event for Defining How New Product Planning Teams and Related Functions Make Informed,...
Black Book Research conducted this flash survey as both a service to the U.S. healthcare industry and a gesture of...
New agreement brings innovative shock wave, tPEMF therapy, monitoring, and bleeding control solutions to more than 2,200 member clinics nationwide...
First-of-its kind tool to guide HCPs on what to consider when staging patients with Mycosis Fungoides and Sézary SyndromePRINCETON, N.J.,...
90-day trial measuring change in general fatigue in chronic babesiosis patientsEnrollment expected to commence Q4 2025 and to be completed...
Submitted New Drug Application (NDA) to the FDA for lead asset CTx-1301Anticipate FDA Decision in Q4 2025 regarding NDA Acceptance...